Sofinnova Capital VII FCPR, 10% Owner at Shockwave Medical, Inc. (SWAV), sold 110,716 shares at $60.01 ($6.6M) on 2020-08-20, disclosed to the SEC on 2020-08-21.
Scheduled sale ($6.6M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.01 | 33,822 | $2.0M | 30.5% |
| 2 | $60.01 | 33,822 | $2.0M | 30.5% |
| 3 | $60.02 | 21,536 | $1.3M | 19.5% |
| 4 | $60.02 | 21,536 | $1.3M | 19.5% |
| Total | $60.01 avg | 110,716 | $6.6M | 100% |
| Filing → |
| SWAV | SELL | 2020-08-10 | $7.3M | — | Filing → |
| SWAV | SELL | 2020-08-05 | $23.0M | — | Filing → |
| SWAV | SELL | 2020-06-11 | $16.0M | — | Filing → |